218 related articles for article (PubMed ID: 36529814)
1. THOR is a targetable epigenetic biomarker with clinical implications in breast cancer.
Apolónio JD; Dias JS; Fernandes MT; Komosa M; Lipman T; Zhang CH; Leão R; Lee D; Nunes NM; Maia AT; Morera JL; Vicioso L; Tabori U; Castelo-Branco P
Clin Epigenetics; 2022 Dec; 14(1):178. PubMed ID: 36529814
[TBL] [Abstract][Full Text] [Related]
2. DNA hypermethylation within TERT promoter upregulates TERT expression in cancer.
Lee DD; Leão R; Komosa M; Gallo M; Zhang CH; Lipman T; Remke M; Heidari A; Nunes NM; Apolónio JD; Price AJ; De Mello RA; Dias JS; Huntsman D; Hermanns T; Wild PJ; Vanner R; Zadeh G; Karamchandani J; Das S; Taylor MD; Hawkins CE; Wasserman JD; Figueiredo A; Hamilton RJ; Minden MD; Wani K; Diplas B; Yan H; Aldape K; Akbari MR; Danesh A; Pugh TJ; Dirks PB; Castelo-Branco P; Tabori U
J Clin Invest; 2019 Jan; 129(1):223-229. PubMed ID: 30358567
[TBL] [Abstract][Full Text] [Related]
3. A cancer specific hypermethylation signature of the TERT promoter predicts biochemical relapse in prostate cancer: a retrospective cohort study.
Castelo-Branco P; Leão R; Lipman T; Campbell B; Lee D; Price A; Zhang C; Heidari A; Stephens D; Boerno S; Coelho H; Gomes A; Domingos C; Apolonio JD; Schäfer G; Bristow RG; Schweiger MR; Hamilton R; Zlotta A; Figueiredo A; Klocker H; Sültmann H; Tabori U
Oncotarget; 2016 Sep; 7(36):57726-57736. PubMed ID: 27437772
[TBL] [Abstract][Full Text] [Related]
4. Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer.
Leão R; Lee D; Figueiredo A; Hermanns T; Wild P; Komosa M; Lau I; Mistry M; Nunes NM; Price AJ; Zhang C; Lipman T; Poyet C; Valtcheva N; Oehl K; Coelho H; Sayyid R; Gomes AM; Prado E Castro L; Sweet J; Vinagre J; Apolónio J; Stephens D; Faleiro I; Fadaak K; Richard PO; Kulkarni G; Zlotta AR; Hamilton RJ; Castelo-Branco P; Tabori U
Int J Cancer; 2019 Apr; 144(7):1676-1684. PubMed ID: 30350309
[TBL] [Abstract][Full Text] [Related]
5. Exploring hTERT promoter methylation in cutaneous T-cell lymphomas.
Chebly A; Ropio J; Peloponese JM; Poglio S; Prochazkova-Carlotti M; Cherrier F; Ferrer J; Idrissi Y; Segal-Bendirdjian E; Chouery E; Farra C; Pham-Ledard A; Beylot-Barry M; Merlio JP; Tomb R; Chevret E
Mol Oncol; 2022 May; 16(9):1931-1946. PubMed ID: 33715271
[TBL] [Abstract][Full Text] [Related]
6. Differential DNA Methylation of THOR and
Ott P; Araúzo-Bravo MJ; Hoffmann MJ; Poyet C; Bendhack ML; Santourlidis S; Erichsen L
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139544
[TBL] [Abstract][Full Text] [Related]
7. The TERT hypermethylated oncologic region predicts recurrence and survival in pancreatic cancer.
Faleiro I; Apolónio JD; Price AJ; De Mello RA; Roberto VP; Tabori U; Castelo-Branco P
Future Oncol; 2017 Oct; 13(23):2045-2051. PubMed ID: 29019414
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer.
Leão R; Apolónio JD; Lee D; Figueiredo A; Tabori U; Castelo-Branco P
J Biomed Sci; 2018 Mar; 25(1):22. PubMed ID: 29526163
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines.
Meeran SM; Patel SN; Tollefsbol TO
PLoS One; 2010 Jul; 5(7):e11457. PubMed ID: 20625516
[TBL] [Abstract][Full Text] [Related]
10. Dual role of allele-specific DNA hypermethylation within the TERT promoter in cancer.
Lee DD; Komosa M; Sudhaman S; Leão R; Zhang CH; Apolonio JD; Hermanns T; Wild PJ; Klocker H; Nassiri F; Zadeh G; Diplas BH; Yan H; Gallinger S; Pugh TJ; Ramaswamy V; Taylor MD; Castelo-Branco P; Nunes NM; Tabori U
J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34720085
[TBL] [Abstract][Full Text] [Related]
11. Regulation and clinical potential of telomerase reverse transcriptase (TERT/hTERT) in breast cancer.
Yang R; Han Y; Guan X; Hong Y; Meng J; Ding S; Long Q; Yi W
Cell Commun Signal; 2023 Aug; 21(1):218. PubMed ID: 37612721
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine accelerates senescence of endothelial cells via DNA hypomethylation of human telomerase reverse transcriptase.
Zhang D; Sun X; Liu J; Xie X; Cui W; Zhu Y
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):71-8. PubMed ID: 25359865
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity.
Guilleret I; Yan P; Grange F; Braunschweig R; Bosman FT; Benhattar J
Int J Cancer; 2002 Oct; 101(4):335-41. PubMed ID: 12209957
[TBL] [Abstract][Full Text] [Related]
14. Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres.
Guilleret I; Benhattar J
Exp Cell Res; 2003 Oct; 289(2):326-34. PubMed ID: 14499633
[TBL] [Abstract][Full Text] [Related]
15. DNA Methylation of the hTERT Gene in Breast Cancer Revisited: Diagnostic and Clinical Implications.
Masood S; El-Gabry E; Zhang C; Wang Z
Lab Med; 2016 Nov; 47(4):293-299. PubMed ID: 27708168
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity, TERT expression, hTERT promoter alterations, and alternative lengthening of the telomeres (ALT) in meningiomas - a systematic review.
Stögbauer L; Stummer W; Senner V; Brokinkel B
Neurosurg Rev; 2020 Jun; 43(3):903-910. PubMed ID: 30788677
[TBL] [Abstract][Full Text] [Related]
17. Targeted demethylation of the CDO1 promoter based on CRISPR system inhibits the malignant potential of breast cancer cells.
Yang J; Sun L; Liu XY; Huang C; Peng J; Zeng X; Zheng H; Cen W; Xu YX; Zhu W; Wu XY; Ling D; Zhang LL; Wei M; Liu Y; Wang D; Wang FH; Li YH; Li Q; Du Z
Clin Transl Med; 2023 Sep; 13(9):e1423. PubMed ID: 37740473
[TBL] [Abstract][Full Text] [Related]
18. Positive regulation of human telomerase reverse transcriptase gene expression and telomerase activity by DNA methylation in pancreatic cancer.
Kumari A; Srinivasan R; Vasishta RK; Wig JD
Ann Surg Oncol; 2009 Apr; 16(4):1051-9. PubMed ID: 19194757
[TBL] [Abstract][Full Text] [Related]
19. Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.
Widschwendter A; Müller HM; Hubalek MM; Wiedemair A; Fiegl H; Goebel G; Mueller-Holzner E; Marth C; Widschwendter M
Gynecol Oncol; 2004 May; 93(2):407-16. PubMed ID: 15099954
[TBL] [Abstract][Full Text] [Related]
20. The potential of identification of a malignancy-associated biomarker in breast cancer diagnosis and research: hTERT gene DNA methylation.
Masood S; El-Gabry E; Zhang C; Wang Z
Diagn Cytopathol; 2016 Aug; 44(8):670-5. PubMed ID: 27229911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
